PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 115 participants.

Also called NCT05174767

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 115 participants (enrolled count) (from the registry)
Sponsor
  • Artivion Inc. Registry lists this organization as the lead sponsor
  • Syneos Health Registry lists this organization as a collaborator
Registry
  • NCT NCT05174767
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05174767. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-27 (actual); primary completion 2023-12-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
Acronym
PERSEVERE
Condition
Acute Aortic Dissection
Intervention (Device)
AMDS
Lead sponsor
Artivion Inc. (class: industry)
Collaborator
Syneos Health (class: other)

Record details

Record id
cardio:ct-nct05174767
Content hash
acce49b2bef800f83e8cf65b41738451a1b87080a864ed1aecd6c6a1de80375f